- American City Business Journals•2 hours ago
Chapel Hill-based Cempra (CEMP) saw its shares boosted Friday after the company announced successful Phase 3 trial results of oral fusidic acid for the treatment of skin infections. The jump is a good sign for Cempra. Ahead of the FDA ruling, Cempra announced the retirement of Prabhavathi Fernandes, the company's former president and CEO.
- 24/7 Wall St.•4 hours ago
Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure infections....
- TheStreet.com•6 hours ago
Other movers include Incyte, Achillion and Inovio.
CEMP : Summary for Cempra, Inc. - Yahoo Finance
Cempra, Inc. (CEMP)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||4.30 x 44300|
|Ask||4.35 x 19400|
|Day's Range||4.00 - 4.75|
|52 Week Range||2.55 - 26.95|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.82|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|